Victory Capital Management Inc United Therapeutics Corp Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 186,819 shares of UTHR stock, worth $72.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
186,819
Previous 153,220 21.93%
Holding current value
$72.2 Million
Previous $48.8 Million 37.16%
% of portfolio
0.07%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$311.04 - $363.55 $10.5 Million - $12.2 Million
33,599 Added 21.93%
186,819 $66.9 Million
Q2 2024

Aug 05, 2024
BUY
$228.26 - $319.04 $1.85 Million - $2.59 Million
8,116 Added 5.59%
153,220 $48.8 Million
Q1 2024

May 03, 2024
BUY
$210.76 - $249.51 $2.31 Million - $2.73 Million
10,942 Added 8.16%
145,104 $33.3 Million
Q4 2023

Feb 05, 2024
BUY
$214.88 - $256.94 $21.8 Million - $26.1 Million
101,419 Added 309.74%
134,162 $29.5 Million
Q3 2023

Nov 06, 2023
BUY
$211.82 - $248.24 $2.15 Million - $2.52 Million
10,140 Added 44.86%
32,743 $7.4 Million
Q2 2023

Jul 27, 2023
SELL
$205.19 - $232.99 $1.22 Million - $1.39 Million
-5,958 Reduced 20.86%
22,603 $4.99 Million
Q1 2023

May 02, 2023
SELL
$212.99 - $276.17 $23,428 - $30,378
-110 Reduced 0.38%
28,561 $6.4 Million
Q4 2022

Feb 10, 2023
BUY
$205.95 - $280.43 $1.25 Million - $1.71 Million
6,086 Added 26.95%
28,671 $7.97 Million
Q4 2022

Feb 09, 2023
BUY
$205.95 - $280.43 $197,712 - $269,212
960 Added 4.44%
22,585 $6.28 Million
Q3 2022

Nov 02, 2022
BUY
$203.3 - $244.17 $1.16 Million - $1.39 Million
5,693 Added 35.73%
21,625 $4.53 Million
Q2 2022

Aug 01, 2022
BUY
$174.81 - $241.14 $10,138 - $13,986
58 Added 0.37%
15,932 $3.75 Million
Q1 2022

May 04, 2022
BUY
$166.16 - $213.96 $648,190 - $834,657
3,901 Added 32.58%
15,874 $2.82 Million
Q4 2021

Feb 07, 2022
SELL
$184.32 - $216.08 $91,975 - $107,823
-499 Reduced 4.0%
11,973 $2.59 Million
Q3 2021

Nov 02, 2021
SELL
$179.86 - $214.88 $155,219 - $185,441
-863 Reduced 6.47%
12,472 $2.3 Million
Q2 2021

Aug 03, 2021
SELL
$170.47 - $211.93 $309,743 - $385,076
-1,817 Reduced 11.99%
13,335 $2.39 Million
Q1 2021

May 04, 2021
SELL
$153.94 - $174.85 $99,445 - $112,953
-646 Reduced 4.09%
15,152 $2.53 Million
Q4 2020

Feb 01, 2021
SELL
$101.87 - $151.79 $451,589 - $672,885
-4,433 Reduced 21.91%
15,798 $2.4 Million
Q3 2020

Nov 09, 2020
SELL
$99.9 - $121.13 $36,563 - $44,333
-366 Reduced 1.78%
20,231 $2.04 Million
Q2 2020

Aug 07, 2020
SELL
$92.74 - $125.82 $190,766 - $258,811
-2,057 Reduced 9.08%
20,597 $2.49 Million
Q1 2020

May 04, 2020
BUY
$79.39 - $115.35 $965,461 - $1.4 Million
12,161 Added 115.9%
22,654 $2.15 Million
Q4 2019

Feb 06, 2020
SELL
$78.31 - $95.34 $652,478 - $794,372
-8,332 Reduced 44.26%
10,493 $924,000
Q4 2019

Feb 04, 2020
BUY
$78.31 - $95.34 $676,285 - $823,356
8,636 Added 84.76%
18,825 $1.84 Million
Q3 2019

Nov 12, 2019
SELL
$74.85 - $85.99 $1.68 Million - $1.93 Million
-22,439 Reduced 68.77%
10,189 $813,000
Q2 2019

Aug 15, 2019
BUY
$76.06 - $120.81 $704,771 - $1.12 Million
9,266 Added 39.66%
32,628 $2.55 Million
Q1 2019

May 03, 2019
BUY
$107.15 - $126.84 $152,688 - $180,747
1,425 Added 6.5%
23,362 $2.74 Million
Q4 2018

Feb 05, 2019
SELL
$101.4 - $128.73 $8,517 - $10,813
-84 Reduced 0.38%
21,937 $2.39 Million
Q3 2018

Nov 01, 2018
BUY
$113.81 - $129.46 $2.51 Million - $2.85 Million
22,021 New
22,021 $2.82 Million
Q3 2017

Oct 27, 2017
SELL
$114.6 - $136.81 $750,515 - $895,968
-6,549 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
6,549
6,549 $850,000

Others Institutions Holding UTHR

# of Institutions
657
Shares Held
42.8M
Call Options Held
153K
Put Options Held
278K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email